Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Anovulation 1

Interventions

epigallocatechin gallate 2Ascorbic Acid 2semaglutide 1salicylsalicylic acid 1microcrystalline cellulose 1dapagliflozin 1cytisine 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1XENP 1595 1Vitamin D 1Topiramate 1Tirzepatide 1Tablets 1Spirometry 1Specimen Handling 1Sodium Salicylate 1Selenium 1Saline Solution 1Resistance Training 1Reperfusion 1Qsymia 1Probiotics 1Pregabalin 1Platelet Count 1Plastic Surgery Procedures 1Phentermine 1Omeprazole 1Naltrexone 1Losartan 1Liraglutide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammation × salicylsalicylic acid × 1 year × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡